A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  Zheng, Liyun ^a,b   Wang, Fuyan ^c   Yang, Zhongdong ^d   Chen, Jianjun ^a   Chang, Haiyan ^c   Chen, Ze ^a,c,d  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c HUNAN NORMAL UNIVERSITY   (China)

^d SHANGHAI INSTITUTE OF BIOLOGICAL PRODUCTS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AVIAN INFLUENZA VACCINE; GAMMA INTERFERON; HA DNA VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 4; UNCLASSIFIED DRUG; DNA VACCINE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ANTIBODY; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; AVIAN INFLUENZA; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG MEGADOSE; ELECTROPORATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; SURVIVAL RATE; VIRUS TITRATION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CHICKEN; IMMUNOLOGY; INFLUENZA VIRUS A H5N1; ORTHOMYXOVIRUS INFECTION; T LYMPHOCYTE; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; CHICKENS; DNA, VIRAL; ELECTROPORATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNITY, CELLULAR; IMMUNIZATION; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; T-LYMPHOCYTES; VACCINES, DNA;

EID: 61949233370     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-17     Document Type: Article

References (50)

1. Lipatov AS Govorkova EA Webby RJ Ozaki H Peiris M Guan Y Poon L Webster RG Influenza: Emergence and control J Virol 2004, 78(17):8951-8959 506949 15308692 10.1128/JVI.78.17.8951-8959.2004
2. Chen H Deng G Li Z Tian G Li Y Jiao P Zhang L Liu Z Webster RG Yu K The evolution of H5N1 influenza viruses in ducks in southern China Proc Natl Acad Sci USA 2004, 101(28):10452-10457 478602 15235128 10.1073/ pnas.0403212101
3. Hinshaw VS Webster RG Turner B The perpetuation of orthomyxoviruses and paramyxoviruses in Canadian waterfowl Can J Microbiol 1980, 26(5):622-629 7397605
4. Sharp NJ Sullivan M Harvey CE Webb T Treatment of canine nasal aspergillosis with enilconazole J Vet Intern Med 1993, 7(1):40-43 8455182
5. Horimoto T Kawaoka Y Influenza: Lessons from past pandemics, warnings from current incidents Nat Rev Microbiol 2005, 3(8):591-600 10.1038/ nrmicro1208 16064053
6. Xu X Subbarao K Cox NJ Guo Y Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: Similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong Virology 1999, 261(1):15-19 10.1006/viro.1999.9820 10484749
7. Kodihalli S Haynes JR Robinson HL Webster RG Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin J Virol 1997, 71(5):3391-3396 191483 9094608
8. Shortridge KF Pandemic influenza: A zoonosis? Semin Respir Infect 1992, 7(1):11-25 1609163
9. Tran TH Nguyen TL Nguyen TD Luong TS Pham PM Nguyen VC Pham TS Vo CD Le TQ Ngo TT et al Avian influenza A (H5N1) in 10 patients in Vietnam N Engl J Med 2004, 350(12):1179-1188 10.1056/NEJMoa040419 14985470
10. Ungchusak K Auewarakul P Dowell SF Kitphati R Auwanit W Puthavathana P Uiprasertkul M Boonnak K Pittayawonganon C Cox NJ et al.: Probable person-to-person transmission of avian influenza A (H5N1) N Engl J Med 2005, 352(4):333-340 10.1056/NEJMoa044021 15668219
11. Normile D Avian influenza. Human transmission but no pandemic in Indonesia Science 2006, 312:5782-1855 10.1126/science.312.5782.1864
12. Lin YP Shaw M Gregory V Cameron K Lim W Klimov A Subbarao K Guan Y Krauss S Shortridge K et al Avian-to-human transmission of H9N2 subtype influenza A viruses: Relationship between H9N2 and H5N1 human isolates Proc Natl Acad Sci USA 2000, 97(17):9654-9658 16920 10920197 10.1073/ pnas.160270697
13. Guan Y Shortridge KF Krauss S Webster RG Molecular characterization of H9N2 influenza viruses: Were they the donors of the "internal" genes of H5N1 viruses in Hong Kong? Proc Natl Acad Sci USA 1999, 96(16):9363-9367 17788 10430948 10.1073/pnas.96.16.9363
14. Lu X Tumpey TM Morken T Zaki SR Cox NJ Katz JM A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans J Virol 1999, 73(7):5903-5911 112651 10364342
15. Middleton D Bingham J Selleck P Lowther S Gleeson L Lehrbach P Robinson S Rodenberg J Kumar M Andrew M Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks Virology 2007, 359(1):66-71 10.1016/j.virol.2006.08.046 17028058
16. Chen H Smith GJ Li KS Wang J Fan XH Rayner JM Vijaykrishna D Zhang JX Zhang LJ Guo CT et al Establishment of multiple sublineages of H5N1 influenza virus in Asia: Implications for pandemic control Proc Natl Acad Sci USA 2006, 103(8):2845-2850 1413830 16473931 10.1073/ pnas.0511120103
17. Kodihalli S Kobasa DL Webster RG Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines Vaccine 2000, 18(23):2592-2599 10.1016/S0264-410X(99)00485-5 10775793
18. Kodihalli S Goto H Kobasa DL Krauss S Kawaoka Y Webster RG DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice J Virol 1999, 73(3):2094-2098 104453 9971791
19. Ljungberg K Wahren B Almqvist J Hinkula J Linde A Winberg G Effective construction of DNA vaccines against variable influenza genes by homologous recombination Virology 2000, 268(2):244-250 10.1006/ viro.2000.0199 10704333
20. Ljungberg K Kolmskog C Wahren B van Amerongen G Baars M Osterhaus A Linde A Rimmelzwaan G DNA vaccination of ferrets with chimeric influenza A virus hemagglutinin (H3) genes Vaccine 2002, 20(16):2045-2052 10.1016/ S0264-410X(02)00049-X 11972972
21. Lee CW Senne DA Suarez DL Development of hemagglutinin subtype-specific reference antisera by DNA vaccination of chickens Avian Dis 2003, 47(3 Suppl):1051-1056 10.1637/0005-2086-47.s3.1051 14575109
22. Cherbonnel M Rousset J Jestin V Strategies to improve protection against low-pathogenicity H7 avian influenza virus infection using DNA vaccines Avian Dis 2003, 47(3 Suppl):1181-1186 10.1637/0005-2086-47.s3.1181 14575138
23. Chen Z Sahashi Y Matsuo K Asanuma H Takahashi H Iwasaki T Suzuki Y Aizawa C Kurata T Tamura S Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza Vaccine 1998, 16(16):1544-1549 10.1016/S0264-410X(98)00043-7 9711802
24. Chen Z Kadowaki S Hagiwara Y Yoshikawa T Matsuo K Kurata T Tamura S Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase Vaccine 2000, 18(28):3214-3222 10.1016/ S0264-410X(00)00149-3 10869766
25. Kadowaki S Chen Z Asanuma H Aizawa C Kurata T Tamura S Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation Vaccine 2000, 18(25):2779-2788 10.1016/S0264-410X(00)00087-6 10812219
26. Chen Z Kadowaki S Hagiwara Y Yoshikawa T Sata T Kurata T Tamura S Protection against influenza B virus infection by immunization with DNA vaccines Vaccine 2001, 19(11-12):1446-1455 10.1016/S0264-410X(00)00351-0 11163667
27. Chen J Fang F Li X Chang H Chen Z Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation Vaccine 2005, 23(34):4322-4328 10.1016/j.vaccine.2005.03.035 15925433
28. Qiu M Fang F Chen Y Wang H Chen Q Chang H Wang F Wang H Zhang R Chen Z Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice Biochem Biophys Res Commun 2006, 343(4):1124-1131 10.1016/ j.bbrc.2006.03.088 16580631
29. Reed LJ Muench H A simple method of estimating fifty per cent endpoints AmJHyg 1938, 27:493-497
30. Niwa H Yamamura K Miyazaki J Efficient selection for high-expression transfectants with a novel eukaryotic vector Gene 1991, 108(2):193-199 10.1016/0378-1119(91)90434-D 1660837
31. Aihara H Miyazaki J Gene transfer into muscle by electroporation in vivo Nat Biotechnol 1998, 16(9):867-870 10.1038/nbt0998-867 9743122
32. Tamura SI Asanuma H Ito Y Hirabayashi Y Suzuki Y Nagamine T Aizawa C Kurata T Oya A Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine Eur J Immunol 1992, 22(2):477-481 10.1002/eji.1830220228 1537382
33. Phelan MA Mayner RE Bucher DJ Ennis FA Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents J Biol Stand 1980, 8(3):233-242 10.1016/ S0092-1157(80)80039-4 7410447
34. Webster RG Kawaoka Y Taylor J Weinberg R Paoletti E Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens Vaccine 1991, 9(5):303-308 10.1016/ 0264-410X(91)90055-B 1651609
35. Laddy DJ Yan J Corbitt N Kobasa D Kobinger GP Weiner DB Immunogenicity of novel consensus-based DNA vaccines against avian influenza Vaccine 2007, 25(16):2984-2989 10.1016/j.vaccine.2007.01.063 17306909
36. Subbarao K Chen H Swayne D Mingay L Fodor E Brownlee G Xu X Lu X Katz J Cox N et al Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics Virology 2003, 305(1):192-200 10.1006/viro.2002.1742 12504552
37. Katz JM The impact of avian influenza viruses on public health Avian Dis 2003, 47(3 Suppl):914-920 10.1637/0005-2086-47.s3.914 14575086
38. Fynan EF Webster RG Fuller DH Haynes JR Santoro JC Robinson HL DNA vaccines: Protective immunizations by parenteral, mucosal, and gene-gun inoculations Proc Natl Acad Sci USA 1993, 90(24):11478-11482 48007 8265577 10.1073/pnas.90.24.11478
39. Ulmer JB Deck RR DeWitt CM Friedman A Donnelly JJ Liu MA Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines Vaccine 1994, 12(16):1541-1544 10.1016/0264-410X(94)90081-7 7879422
40. Johnson PA Conway MA Daly J Nicolson C Robertson J Mills KH Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses J Gen Virol 2000, 81:1737-1745 10859379
41. Deck RR DeWitt CM Donnelly JJ Liu MA Ulmer JB Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine Vaccine 1997, 15(1):71-78 10.1016/S0264-410X(96)00101-6 9041669
42. Tsang C Babiuk S van Drunen Littel-van den Hurk S Babiuk LA Griebel P A single DNA immunization in combination with electroporation prolongs the primary immune response and maintains immune memory for six months Vaccine 2007, 25(30):5485-5494 10.1016/j.vaccine.2007.03.009 17408815
43. Kuklin N Daheshia M Karem K Manickan E Rouse BT Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization J Virol 1997, 71(4):3138-3145 191446 9060677
44. Riberdy JM Flynn KJ Stech J Webster RG Altman JD Doherty PC Protection against a lethal avian influenza A virus in a mammalian system J Virol 1999, 73(2):1453-1459 103970 9882351
45. Pertmer TM Roberts TR Haynes JR Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery J Virol 1996, 70(9):6119-6125 190634 8709236
46. Feltquate DM Heaney S Webster RG Robinson HL Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization J Immunol 1997, 158(5):2278-2284 9036975
47. Treanor JJ Campbell JD Zangwill KM Rowe T Wolff M Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine N Engl J Med 2006, 354(13):1343-1351 10.1056/NEJMoa055778 16571878
48. Leroux-Roels I Borkowski A Vanwolleghem T Drame M Clement F Hons E Devaster JM Leroux-Roels G Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: A randomised controlled trial Lancet 2007, 370(9587):580-589 10.1016/ S0140-6736(07)61297-5 17707753
49. Nolan TM Richmond PC Skeljo MV Pearce G Hartel G Formica NT Hoschler K Bennet J Ryan D Papanaoum K et al Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults Vaccine 2008, 26(33):4160-4167 10.1016/j.vaccine.2008.05.077 18599164
50. Nolan T Richmond PC Formica NT Hoschler K Skeljo MV Stoney T McVernon J Hartel G Sawlwin DC Bennet J et al Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children Vaccine 2008, 26(50):6383-6391 10.1016/ j.vaccine.2008.08.046 18801398